Prothena Corporation Public Limited Company Revenue per Employee (PRTA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Prothena Corporation Public Limited Company  (NASDAQ: PRTA)
 

Prothena Public Limited's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Prothena Public Limited's Revenue per employee fell on a trailing twelve month basis to $ 813,881, but the productivity of Prothena Public Limited's employees remained above the company average.
Within the Healthcare sector Employees of 93 other companies have achieved higher revenue per employee. While Prothena Public Limited's total ranking has deteriorated compared to the previous quarter from 677 to 1002. Prothena Public Limited has 67 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRTA Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -77.15 % 1706.36 % -99.01 % 148.97 % -96.65 %
Sales per Employee (TTM) $ 813,881 864,776 144,537 175,910 154,343
PRTA's Total Ranking # 1002 # 677 # 2282 # 2334 # 2782
Seq. Revenue Change -98.02 % 243157.14 % -99.13 % -45.36 % 56.29 %

PRTA Company Profile >> Back to PRTA Efficiency Comparisons >> Compare PRTA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 68
Healthcare Sector # 94
Overall Market # 1002

Revenue per Employee Statistics
High Average Low
$ 3,242,478 $ 700,810 $ 10,090
(Jun 30 2024)   (Dec 31 2013)



Financial Statements
Prothena Public Limited's Revenue MRQ $ 1 Millions Visit PRTA's Income Statement
Prothena Public Limited's Revenues TTM $ 55 Millions Visit PRTA's aggregate revenue growth
What are PRTA's Sales? Visit PRTA's Sales by Segment




Other Ratios
Prothena Public Limited's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PRTA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PRTA's Competitors
Revenue per Employee for PRTA's Suppliers
Revenue per Employee for PRTA's Customers

You may also want to know
PRTA's Sales Growth Rates PRTA's Pe Price to earnings ratio PRTA's Receivables Turnover Ratio PRTA's Stock Quote
PRTA's Net Income Growth Rates PRTA's Ps Price to Sales ratio PRTA's Sales per Employee PRTA's Asset Turnover Ratio
PRTA's Net Margin PRTA's Pb Price to Book ratio PRTA's Financial Strength Ratios PRTA's Dividend Payout Ratio
Date modified: 2026-09-08T21:44:20+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Madrigal Pharmaceuticals Inc   1,403,213.11 $ 1,283.940  Million 915 
Indivior Pharmaceuticals Inc   1,333,000.00 $ 1,333.000  Million 1,000 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Supernus Pharmaceuticals inc   1,273,677.91 $ 830.438  Million 652 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Abbvie Inc   1,129,578.95 $ 64,386.000  Million 57,000 
Akebia Therapeutics Inc   1,129,175.26 $ 219.060  Million 194 
Siga Technologies Inc  1,095,079.92 $ 53.659  Million 49 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ptc Therapeutics inc   1,017,915.24 $ 1,008.754  Million 991 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Regeneron Pharmaceuticals Inc   1,008,092.15 $ 15,534.700  Million 15,410 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million 8 
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Evolus Inc   949,440.12 $ 317.113  Million 334 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
Ardelyx inc   922,073.62 $ 450.894  Million 489 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.